Previous close | 10.80 |
Open | 9.90 |
Bid | 6.00 |
Ask | 11.00 |
Strike | 52.50 |
Expiry date | 2026-01-16 |
Day's range | 6.80 - 10.80 |
Contract range | N/A |
Volume | |
Open interest | 2 |
Catalent's (CTLT) new tie-up to support the development and commercial manufacturing of safe, high-quality AAV gene therapies to provide life-saving treatments to cancer patients.
Catalent (CTLT) reports a solid revenue uptick in third-quarter fiscal 2024 despite lower revenues in Biologics segments.
Insightful Analysis of Catalent Inc's Strengths, Weaknesses, Opportunities, and Threats